Gemcitabine, fludarabine and melphalan for reduced-intensity conditioning and allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Por Anderlini, Paolo, Saliba, Rima M., Ledesma, Celina, Plair, Tamera, Alousi, Amin M., Hosing, Chitra M., Khouri, Issa F., Nieto, Yago, Popat, Uday R., Shpall, Elizabeth J, Fanale, Michelle A., Hagemeister, Frederick B., Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E., Younes, Anas, Champlin, Richard E.
Publicado no Biol Blood Marrow Transplant (2016)

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Por Westin, Jason R., Thompson, Michael A., Cataldo, Vince D., Fayad, Luis E., Fowler, Nathan, Fanale, Michelle A., Neelapu, Saatva, Samaniego, Felipe, Romaguera, Jorge, Shah, Jatin, McLaughlin, Peter, Pro, Barbara, Kwak, Larry W., Sanjorjo, Perpetua, Murphy, William A., Jimenez, Camillo, Toth, Bela, Dong, Wenli, Hagemeister, Fredrick B.
Publicado em 2012